The 15 Highest Grossing Prescription Drugs In America

Pill Pop America

Photo: icebluess via flickr

American patients spent $307 billion on prescription drugs in 2010, up 2.4% from the past year according to IMS Institute for Healthcare Informatics.AstraZeneca’s Crestor posted the biggest increase with $770 million in new sales.

Name brand medicine, however, have been losing out to generics. Generics now make up 78% of total prescriptions, up from 63% just four years ago.

Spending on Pfizer’s Lipitor, America’s highest-grossing drug, has dropped in each of the past five years. With a patent expiring in 2011 it will compete with new generics entering the market.

Seroquel, another top seller, will lose patent protection in 2012.

#15 Oxycontin

Made by Purdue Pharma. Used as a painkiller for moderate to severe pain .

Gross: $3.0 billion

One-year growth: 6.9%

Five-year growth: 287.5%

Sales data from the IMS Institute for Healthcare Informatics

#14 Avastin

Made by Genentech. Used by cancer patients as part of 'tumour-starving' therapy.

Gross: $3.1 billion

One-year growth: 3.3%

Five-year growth: 82.4%

Sales data from the IMS Institute for Healthcare Informatics

#13 Cymbalta

Made by Eli Lilly & Co. (LLY). Used to treat depression and anxiety disorders.

Gross: $3.2

One-year growth: 14.2%

Five-year growth: 166.7%

Sales data from the IMS Institute for Healthcare Informatics

#12 Enbrel

Made by Amgen (AMGN) and Pfizer (PFE). Used to treat inflammatory diseases including arthritis.

Gross: $3.3 billion

One-year growth: 0%

Five-year growth: 6.5%

Sales data from the IMS Institute for Healthcare Informatics

#11 Remicade

Made by Centocor. Used to treat Crohn's Disease and rheumatoid arthritis.

Gross: $3.3 billion

One-year growth: 3.1%

Five-year growth: 32%

Sales data from the IMS Institute for Healthcare Informatics

#10 Epogen

Made by Amgen (AMGN). Used by patients with chronic kidney failure to treat anemia.

Gross: $3.3 billion

One-year growth: 3.1%

Five-year growth: 3.1%

Sales data from the IMS Institute for Healthcare Informatics

#9 Actos

Made by Takeda. Used to treat Type 2 diabetes.

Gross: $3.5 billion

One-year growth: 2.9%

Five-year growth: 34.6%

Sales data from the IMS Institute for Healthcare Informatics

#8 Crestor

Made by AstraZeneca (AZN). Used to reduce cholesterol.

Gross: $3.8 billion

One-year growth: 26.7%

Five-year growth: 192.3%

Sales data from the IMS Institute for Healthcare Informatics

#7 Singulair

Made by Merck. Used to treat asthma.

Gross: $4.1 billion

One-year growth: 10.8%

Five-year growth: 36.7%

Sales data from the IMS Institute for Healthcare Informatics

#6 Seroquel

Made by AstraZeneca (AZN). Used to treat schizophrenia and bipolar disorder .

Gross: $4.4 billion

One-year growth: 4.8%

Five-year growth: 46.7%

Sales data from the IMS Institute for Healthcare Informatics

#5 Abilify

Made by Otsuka and Bristol-Myers Squibb (BMY). Used to treat schizophrenia and bipolar disorder.

Gross: $4.6 billion

One-year growth: 15%

Five-year growth: 142.1%

Sales data from the IMS Institute for Healthcare Informatics

#4 Advair Diskus

Made by GlaxoSmithKline (GSK). Used to treat asthma symptoms.

Gross: $4.7 billion

One-year growth: 0%

Five-year growth: 20.5%

Sales data from the IMS Institute for Healthcare Informatics

#3 Plavix

Made by Bristol-Myers Squibb (BMY) and Sanofi Pharmaceuticals. Used to prevent blood clots by patients at risk for strokes and heart attacks.

Gross: $6.1 billion

One-year growth: 8.9%

Five-year growth: 110.3%

Sales data from the IMS Institute for Healthcare Informatics

#2 Nexium

Made by AstraZeneca (AZN). Used by patients with acid reflux to treat heart burn.

Gross: $6.3 billion

One-year growth: 0%

Five-year growth: 23.5%

Sales data from the IMS Institute for Healthcare Informatics

#1 Lipitor

Made by Pfizer (PFE). Used to reduce the risk of heart attack and stroke.

Gross: $7.2 billion

One-year growth: -5.3%

Five-year growth: -16%

Sales data from the IMS Institute for Healthcare Informatics

Did you know that medical bills are the number one reason for bankruptcy in the US?

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.